Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371720 · ClinicalTrials.gov registry record · NA
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT02371720: Completed NA study, sponsored by Emory University.
NCT02371720 is a NA study that has completed, run by Emory University. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02371720, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn about ways to help children and adults with sickle cell disease who are taking the medication, hydroxyurea.
Primary Outcome
Proportion of days the patient is in possession of the medication in the study period
Interventions
- BEHAVIORAL Mobile DOT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT02371720 record still lists
NCT02371720 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile DOT is the first listed.
NCT02371720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02371720 about?
NCT02371720 is a clinical study titled "Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease". The purpose of this research study is to learn about ways to help children and adults with sickle cell disease who are taking the medication, hydroxyurea.
What is the current status of trial NCT02371720?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2014-06-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02371720?
The interventions under investigation include: Mobile DOT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02371720?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02371720's enrollment target sits among peer trials
164 626th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI